Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 6
2017 4
2018 7
2019 7
2020 5
2021 11
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
IL-1 Signaling in Tumor Microenvironment.
Zhang W, Borcherding N, Kolb R. Zhang W, et al. Adv Exp Med Biol. 2020;1240:1-23. doi: 10.1007/978-3-030-38315-2_1. Adv Exp Med Biol. 2020. PMID: 32060884 Review.
Obesity and cancer: inflammation bridges the two.
Kolb R, Sutterwala FS, Zhang W. Kolb R, et al. Curr Opin Pharmacol. 2016 Aug;29:77-89. doi: 10.1016/j.coph.2016.07.005. Epub 2016 Jul 16. Curr Opin Pharmacol. 2016. PMID: 27429211 Free PMC article. Review.
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity.
Khan S, Zhang X, Lv D, Zhang Q, He Y, Zhang P, Liu X, Thummuri D, Yuan Y, Wiegand JS, Pei J, Zhang W, Sharma A, McCurdy CR, Kuruvilla VM, Baran N, Ferrando AA, Kim YM, Rogojina A, Houghton PJ, Huang G, Hromas R, Konopleva M, Zheng G, Zhou D. Khan S, et al. Nat Med. 2019 Dec;25(12):1938-1947. doi: 10.1038/s41591-019-0668-z. Epub 2019 Dec 2. Nat Med. 2019. PMID: 31792461 Free PMC article.
Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy.
Sun Y, Chen W, Torphy RJ, Yao S, Zhu G, Lin R, Lugano R, Miller EN, Fujiwara Y, Bian L, Zheng L, Anand S, Gao F, Zhang W, Ferrara SE, Goodspeed AE, Dimberg A, Wang XJ, Edil BH, Barnett CC, Schulick RD, Chen L, Zhu Y. Sun Y, et al. Sci Transl Med. 2021 Jul 28;13(604):eabc8922. doi: 10.1126/scitranslmed.abc8922. Sci Transl Med. 2021. PMID: 34321321 Free PMC article.
Unleashing the Power of NR4A1 Degradation as a Novel Strategy for Cancer Immunotherapy.
Wang L, Xiao Y, Luo Y, Master RP, Mo J, Kim MC, Liu Y, Patel UM, Li X, Shaffer D, Guertin KR, Moser E, Smalley KS, Zhou D, Zheng G, Zhang W. Wang L, et al. bioRxiv [Preprint]. 2023 Aug 13:2023.08.09.552650. doi: 10.1101/2023.08.09.552650. bioRxiv. 2023. Update in: J Exp Med. 2024 Mar 4;221(3):e20231519. doi: 10.1084/jem.20231519. PMID: 37609171 Free PMC article. Updated. Preprint.
41 results